Cargando…
Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
OBJECTIVE: To assess performance on an age-standardized neuromotor coordination task among sulfonylurea-treated KCNJ11-related neonatal diabetic patients. RESEARCH DESIGN AND METHODS: Nineteen children carrying KCNJ11 mutations associated with isolated diabetes (R201H; n = 8), diabetes with neurodev...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447845/ https://www.ncbi.nlm.nih.gov/pubmed/22855734 http://dx.doi.org/10.2337/dc11-2225 |
_version_ | 1782244176086171648 |
---|---|
author | Shah, Reshma P. Spruyt, Karen Kragie, Brigette C. Greeley, Siri Atma W. Msall, Michael E. |
author_facet | Shah, Reshma P. Spruyt, Karen Kragie, Brigette C. Greeley, Siri Atma W. Msall, Michael E. |
author_sort | Shah, Reshma P. |
collection | PubMed |
description | OBJECTIVE: To assess performance on an age-standardized neuromotor coordination task among sulfonylurea-treated KCNJ11-related neonatal diabetic patients. RESEARCH DESIGN AND METHODS: Nineteen children carrying KCNJ11 mutations associated with isolated diabetes (R201H; n = 8), diabetes with neurodevelopmental impairment (V59M or V59A [V59M/A]; n = 8), or diabetes not consistently associated with neurodevelopmental disability (Y330C, E322K, or R201C; n = 3) were studied using the age-standardized Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI). RESULTS: Although R201H subjects tested in the normal range (median standard score = 107), children with V59M/A mutations had significantly lower than expected VMI standard scores (median = 49). The scores for all three groups were significantly different from each other (P = 0.0017). The age of sulfonylurea initiation was inversely correlated with VMI scores in the V59M/A group (P < 0.05). CONCLUSIONS: Neurodevelopmental disability in KCNJ11-related diabetes includes visuomotor problems that may be ameliorated by early sulfonylurea treatment. Comprehensive longitudinal assessment on larger samples will be imperative. |
format | Online Article Text |
id | pubmed-3447845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-34478452013-10-01 Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas Shah, Reshma P. Spruyt, Karen Kragie, Brigette C. Greeley, Siri Atma W. Msall, Michael E. Diabetes Care Original Research OBJECTIVE: To assess performance on an age-standardized neuromotor coordination task among sulfonylurea-treated KCNJ11-related neonatal diabetic patients. RESEARCH DESIGN AND METHODS: Nineteen children carrying KCNJ11 mutations associated with isolated diabetes (R201H; n = 8), diabetes with neurodevelopmental impairment (V59M or V59A [V59M/A]; n = 8), or diabetes not consistently associated with neurodevelopmental disability (Y330C, E322K, or R201C; n = 3) were studied using the age-standardized Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI). RESULTS: Although R201H subjects tested in the normal range (median standard score = 107), children with V59M/A mutations had significantly lower than expected VMI standard scores (median = 49). The scores for all three groups were significantly different from each other (P = 0.0017). The age of sulfonylurea initiation was inversely correlated with VMI scores in the V59M/A group (P < 0.05). CONCLUSIONS: Neurodevelopmental disability in KCNJ11-related diabetes includes visuomotor problems that may be ameliorated by early sulfonylurea treatment. Comprehensive longitudinal assessment on larger samples will be imperative. American Diabetes Association 2012-10 2012-09-11 /pmc/articles/PMC3447845/ /pubmed/22855734 http://dx.doi.org/10.2337/dc11-2225 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Shah, Reshma P. Spruyt, Karen Kragie, Brigette C. Greeley, Siri Atma W. Msall, Michael E. Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas |
title | Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas |
title_full | Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas |
title_fullStr | Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas |
title_full_unstemmed | Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas |
title_short | Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas |
title_sort | visuomotor performance in kcnj11-related neonatal diabetes is impaired in children with dend-associated mutations and may be improved by early treatment with sulfonylureas |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447845/ https://www.ncbi.nlm.nih.gov/pubmed/22855734 http://dx.doi.org/10.2337/dc11-2225 |
work_keys_str_mv | AT shahreshmap visuomotorperformanceinkcnj11relatedneonataldiabetesisimpairedinchildrenwithdendassociatedmutationsandmaybeimprovedbyearlytreatmentwithsulfonylureas AT spruytkaren visuomotorperformanceinkcnj11relatedneonataldiabetesisimpairedinchildrenwithdendassociatedmutationsandmaybeimprovedbyearlytreatmentwithsulfonylureas AT kragiebrigettec visuomotorperformanceinkcnj11relatedneonataldiabetesisimpairedinchildrenwithdendassociatedmutationsandmaybeimprovedbyearlytreatmentwithsulfonylureas AT greeleysiriatmaw visuomotorperformanceinkcnj11relatedneonataldiabetesisimpairedinchildrenwithdendassociatedmutationsandmaybeimprovedbyearlytreatmentwithsulfonylureas AT msallmichaele visuomotorperformanceinkcnj11relatedneonataldiabetesisimpairedinchildrenwithdendassociatedmutationsandmaybeimprovedbyearlytreatmentwithsulfonylureas |